J. A. Este, T. Cihlar, K. J. Cortez, and F. Maldarelli, Current status and challenges of antiretroviral research and therapy (3) (a) Mene?ndezMene?ndez-Arias, L. Molecular basis of human immunodeficiency virus drug resistance: an update Clinical management of HIV drug resistance (c) Howkins, T. Understanding and managing the adverse effects of antiretroviral therapy, Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: a review over the last 20 years, pp.25-33, 1989.

Z. K. Sweeney, K. Klumpp, and R. Haubrich, Improving non-nucleoside reverse transcriptase inhibitors for first-line treatment of HIV infection: the development pipeline and recent clinical data, Antiviral Res Curr. Opin. Drug Discovery Dev, vol.85, issue.11 458?4705, pp.75-90, 2008.

2. Etravirine, F. Drugs@, R. Silvestri, G. De-martino, G. La-regina et al., FDA approved drug products Novel indolyl aryl sulfones active against HIV-1 carrying NNRTI resistance mutations: synthesis and SAR studies Simple, short peptide derivatives of a sulfonylindolecarboxamide (L-737,126) active in vitro against HIV-1 wild-type and variants carrying non-nucleoside reverse transcriptase inhibitor resistance mutations, Nature Rev. Drug Discovery J. Med. Chem. J. Med. Chem, vol.46, issue.6, pp.47-3892, 2003.

L. Torre, F. Lavecchia, A. Novellino, E. Silvestri, and R. , Indolylarylsulfones bearing natural and unnatural amino acids. Discovery of potent inhibitors of HIV-1 non-nucleoside wild type and resistant mutant strains reverse transcriptase and Coxsackie B4 virus, J. Med

A. Sinistro, -hydroxyethyl)carboxyamide and N-(2-hydroxyethyl)- carboxyhydrazide derivatives, J. Med. Chem. C, vol.48, issue.2, 2005.

G. Maga, E. Crespan, M. Artico, R. L. Silvestri, G. Regina et al., Design, molecular modeling, synthesis and anti-HIV-1 activity of new indolyl aryl sulfones. Novel derivatives of the indole-2-carboxamide Looking for an active conformation of the future HIV-1 non-nucleoside reverse transcriptase inhibitors, J. Med. Chem. Antiviral Chem. Chemother. C, vol.49, issue.2010, pp.3172-3184, 2006.

E. Novellino, R. Silvestri, J. W. Corbett, and J. Rodgers, Indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors. New cyclic substituents at the indole-2- carboxamide Discovery of second generation of quinazoline non-nucleoside reverse transcriptase inhibitors of HIV-1, J. Med. Chem, vol.54, issue.11, pp.1587-1598, 2011.

M. Botta, Parallel solution-phase and microwave-assisted synthesis of new S-DABO derivatives endowed with subnanomolar anti-HIV-1 activity, J. Med. Chem. Journal of Medicinal Chemistry Brief Article J. Med. Chem, vol.55, pp.6634-6638, 2005.